Skip to main content

Canada s Structural Genomics Consortium Wins $95M Proteomics Grant

NEW YORK, April 3 - GlaxoSmithKline, the government of Ontario, and two regional research trusts have awarded Canada's Structural Genomics Consortium $95 million to perform proteomics studies into a number of diseases, the SGC said today.


The British pharma giant together with the government of Ontario Premier Ernie Eves, the Ontario Innovation Trust, and the Ontario Research and Development Challenge Fund have raised  the money to help the SGC investigate 350 human proteins links to certain cancers, neurological disorders, and infectious diseases.


The three-year project, which will be led by Canadian scientist Aled Edwards, involves scientists based at the University of Toronto and the University of Oxford, UK, the Wellcome Trust, Genome Canada, and Canadian Institutes of Health Research.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.